SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001828185-24-000036
Filing Date
2024-05-13
Accepted
2024-05-13 08:13:41
Documents
75
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q brns-20240331.htm   iXBRL 10-Q 837622
2 EX-31.1 brns-20240331xexx311.htm EX-31.1 11098
3 EX-31.2 brns-20240331xexx312.htm EX-31.2 11040
4 EX-32.1 brns-20240331xexx321.htm EX-32.1 6423
10 brns-20240331_g1.jpg GRAPHIC 932443
  Complete submission text file 0001828185-24-000036.txt   6746606

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT brns-20240331.xsd EX-101.SCH 42196
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT brns-20240331_cal.xml EX-101.CAL 61740
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT brns-20240331_def.xml EX-101.DEF 174303
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT brns-20240331_lab.xml EX-101.LAB 491193
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT brns-20240331_pre.xml EX-101.PRE 331546
79 EXTRACTED XBRL INSTANCE DOCUMENT brns-20240331_htm.xml XML 384156
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40367 | Film No.: 24936986
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)